Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Oliver Klein, Christopher Schmidt, Ashley Knights, Ian D Davis, Weisan Chen & Jonathan Cebon. (2011) Melanoma vaccines: developments over the past 10 years. Expert Review of Vaccines 10:6, pages 853-873.
Read now
Read now
A ML Coluccia, R H Gunby, C J Tartari, L Scapozza, C Gambacorti-Passerini & Lorena Passoni. (2005) Anaplastic lymphoma kinase and its signalling molecules as novel targets in lymphoma therapy. Expert Opinion on Therapeutic Targets 9:3, pages 515-532.
Read now
Read now
Michael Campoli & Soldano Ferrone. (2004) T-cell-based immunotherapy of melanoma: what have we learned and how can we improve?. Expert Review of Vaccines 3:2, pages 171-187.
Read now
Read now
Articles from other publishers (72)
Mads Hald Andersen. (2022) Tumor microenvironment antigens. Seminars in Immunopathology 45:2, pages 253-264.
Crossref
Crossref
Ward Doelman & Sander I. van Kasteren. (2022) Synthesis of glycopeptides and glycopeptide conjugates. Organic & Biomolecular Chemistry 20:33, pages 6487-6507.
Crossref
Crossref
Daniel Martinez-Perez, David Viñal, Isabel Solares, Enrique Espinosa & Jaime Feliu. (2021) Gp-100 as a Novel Therapeutic Target in Uveal Melanoma. Cancers 13:23, pages 5968.
Crossref
Crossref
David Bassan, Yosi Meir Gozlan, Adi Sharbi‐Yunger, Esther Tzehoval & Lea Eisenbach. (2019) Optimizing T‐cell receptor avidity with somatic hypermutation. International Journal of Cancer 145:10, pages 2816-2826.
Crossref
Crossref
Dawei YuJing WangHuiying ZouTao FengLei ChenJia LiXiaolan QiZhifang LiXiaoyue DuanChunlong XuLiang ZhangXi LongJing LanChao ChenChao WangXinyu XuJilong RenYiqiang ZhaoXiaoxiang HuZhengxing LianHongsheng MenDengke PanNing LiMario R. Capecchi, Xuguang DuYaofeng ZhaoSen Wu. (2018) Silencing of retrotransposon-derived imprinted gene RTL1 is the main cause for postimplantational failures in mammalian cloning. Proceedings of the National Academy of Sciences 115:47.
Crossref
Crossref
Vanessa Sainz, Liane I.F. Moura, Carina Peres, Ana I. Matos, Ana S. Viana, Angela M. Wagner, Julia E. Vela Ramirez, Teresa S. Barata, Manuela Gaspar, Steve Brocchini, Mire Zloh, Nicholas A. Peppas, Ronit Satchi-Fainaro & Helena F. Florindo. (2018) α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma. Acta Biomaterialia 76, pages 193-207.
Crossref
Crossref
Beom K. Choi, Seon-Hee Kim, Young H. Kim & Byoung S. Kwon. (2018) Cancer immunotherapy using tumor antigen-reactive T cells. Immunotherapy 10:3, pages 235-245.
Crossref
Crossref
Chantale Bernatchez, Zachary A. Cooper, Jennifer A. Wargo, Patrick Hwu & Gregory Lizée. 2016. Melanoma. Melanoma
371
416
.
Connie P.M. Duong, Carmen S.M. Yong, Michael H. Kershaw, Clare Y. Slaney & Phillip K. Darcy. (2015) Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic. Molecular Immunology 67:2, pages 46-57.
Crossref
Crossref
Wanyong Zeng, Mei Su, Karen S. Anderson & Tetsuro Sasada. (2014) Artificial antigen-presenting cells expressing CD80, CD70, and 4-1BB ligand efficiently expand functional T cells specific to tumor-associated antigens. Immunobiology 219:8, pages 583-592.
Crossref
Crossref
Salequl Islam, Sheikh Ariful Hoque, Nihad Adnan, Atsushi Tanaka, Atsushi Jinno‐Oue & Hiroo Hoshino. (2013)
X4‐tropic human immunodeficiency virus
IIIB
utilizes
CXCR
4 as coreceptor, as distinct from R5X4‐tropic viruses
. Microbiology and Immunology 57:6, pages 437-444.
Crossref
Crossref
Tara L Spivey, Valeria De Giorgi, Yingdong Zhao, Davide Bedognetti, Zoltan Pos, Qiuzhen Liu, Sara Tomei, Maria Libera Ascierto, Lorenzo Uccellini, Jennifer Reinboth, Lotfi Chouchane, David F Stroncek, Ena Wang & Francesco M Marincola. (2012) The stable traits of melanoma genetics: an alternate approach to target discovery. BMC Genomics 13:1.
Crossref
Crossref
Dung T. Le, Thomas W. DubenskyJr.Jr. & Dirk G. Brockstedt. (2012) Clinical Development of Listeria monocytogenes?Based Immunotherapies. Seminars in Oncology 39:3, pages 311-322.
Crossref
Crossref
Timothy J. HaggertyIan S. DunnLenora B. RoseEstelle E. NewtonJames T. Kurnick. (2012) A Screening Assay to Identify Agents That Enhance T-Cell Recognition of Human Melanomas. ASSAY and Drug Development Technologies 10:2, pages 187-201.
Crossref
Crossref
Tetsuro SasadaShigetaka Suekane. (2011) Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance. Immunotherapy 3:10, pages 1235-1251.
Crossref
Crossref
Jacques Thibodeau, Marie-Claude Bourgeois-Daigneault & Réjean Lapointe. 2011. Experimental and Applied Immunotherapy. Experimental and Applied Immunotherapy
173
194
.
David K. Cole, Fang Yuan, Pierre J. Rizkallah, John J. Miles, Emma Gostick, David A. Price, George F. Gao, Bent K. Jakobsen & Andrew K. Sewell. (2009) Germ Line-governed Recognition of a Cancer Epitope by an Immunodominant Human T-cell Receptor. Journal of Biological Chemistry 284:40, pages 27281-27289.
Crossref
Crossref
Hai Zhen Song, Michihiro Kono & Yasushi Tomita. (2009) Establishment of a Screening System for Chemicals that Upregulate a Melanoma Antigen, Melan-A/MART-1. The Tohoku Journal of Experimental Medicine 217:3, pages 231-237.
Crossref
Crossref
Gali Soria & Adit Ben-Baruch. 2009. Chemokine Receptors in Cancer. Chemokine Receptors in Cancer
109
130
.
Jamie Poust. (2008) Targeting metastatic melanoma. American Journal of Health-System Pharmacy 65:24_Supplement_9, pages S9-S15.
Crossref
Crossref
Samudra K. Dissanayake, Purevdorj B. Olkhanud, Michael P. O'Connell, Arnell Carter, Amanda D. French, Tura C. Camilli, Chineye D. Emeche, Kyle J. Hewitt, Devin T. Rosenthal, Poloko D. Leotlela, Michael S. Wade, Sherry W. Yang, Larry Brant, Brian J. Nickoloff, Jane L. Messina, Arya Biragyn, Keith S. Hoek, Dennis D. Taub, Dan L. Longo, Vernon K. Sondak, Stephen M. Hewitt & Ashani T. Weeraratna. (2008) Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 Phosphorylation. Cancer Research 68:24, pages 10205-10214.
Crossref
Crossref
Katy L. Wiltz, Hina Qureshi, James W. Patterson, Daniel C. Mayes & Mark R. Wick. (2007) Immunostaining for MART-1 in the interpretation of problematic intra-epidermal pigmented lesions. Journal of Cutaneous Pathology 34:8, pages 601-605.
Crossref
Crossref
Maria Stepanova, Tatiana Tiazhelova, Mikle Skoblov & Ancha Baranova. (2006) Potential regulatory SNPs in promoters of human genes: A systematic approach. Molecular and Cellular Probes 20:6, pages 348-358.
Crossref
Crossref
Rienk Offringa. (2006) Cancer Immunotherapy Is More Than a Numbers Game. Science 314:5796, pages 68-69.
Crossref
Crossref
Kepa Oyarbide-Valencia, Jasper G. van den Boorn, Cecele J. Denman, Mingli Li, Jeremy M. Carlson, Claudia Hernandez, Michael I. Nishimura, Pranab K. Das, Rosalie M. Luiten & I. Caroline Le Poole. (2006) Therapeutic implications of autoimmune vitiligo T cells. Autoimmunity Reviews 5:7, pages 486-492.
Crossref
Crossref
Edward J. Dunphy, Laura E. Johnson, Brian M. Olson, Thomas P. Frye & Douglas G. McNeel. (2006) New approaches to identification of antigenic candidates for future prostate cancer immunotherapy. Update on Cancer Therapeutics 1:2, pages 273-284.
Crossref
Crossref
Siguo HaoZhenmin YeJicheng YangOu BaiJim Xiang. (2006) Intradermal Vaccination of Dendritic Cell–Derived Exosomes Is Superior to a Subcutaneous One in the Induction of Antitumor Immunity. Cancer Biotherapy and Radiopharmaceuticals 21:2, pages 146-154.
Crossref
Crossref
M.R. Hussein. (2005) Tumour-infiltrating lymphocytes and melanoma tumorigenesis: an insight. British Journal of Dermatology 153:1, pages 18-21.
Crossref
Crossref
Kimberly A Chianese-Bullock, Elizabeth M. H Woodson, Huimin Tao, Scott A Boerner, Mark Smolkin, William W Grosh, Patrice Y Neese, Priscilla Merrill, Gina R Petroni & Craig L Slingluff. (2005) Autoimmune Toxicities Associated with the Administration of Antitumor Vaccines and Low-Dose Interleukin-2. Journal of Immunotherapy 28:4, pages 412-419.
Crossref
Crossref
Hitomi Kaneko, Toshiyuki Hori, Soshi Yanagita, Norimitsu Kadowaki & Takashi Uchiyama. (2005) Introduction of OX40 ligand into lymphoma cells elicits anti-lymphoma immunity in vivo. Experimental Hematology 33:3, pages 336-343.
Crossref
Crossref
Jianping Huang, Mona El-Gamil, Mark E. Dudley, Yong F. Li, Steven A. Rosenberg & Paul F. Robbins. (2004)
T Cells Associated with Tumor Regression Recognize Frameshifted Products of the
CDKN2A
Tumor Suppressor Gene Locus and a Mutated HLA Class I Gene Product
. The Journal of Immunology 172:10, pages 6057-6064.
Crossref
Crossref
Jeffrey R. Johnson, Laurence Florens, Daniel J. Carucci & John R. Yates. (2004) Proteomics in Malaria. Journal of Proteome Research 3:2, pages 296-306.
Crossref
Crossref
Ena Wang & Francesco M. Marincola. 2004. Cancer Immunotherapy at the Crossroads. Cancer Immunotherapy at the Crossroads
237
255
.
Luis E Raez, Peter A Cassileth, James J Schlesselman, Swaminathan Padmanabhan, Eva Z Fisher, Paulette A Baldie, Kasi Sridhar & Eckhard R Podack. (2003) Induction of CD8 T-cell-Ifn-γ response and positive clinical outcome after immunization with gene-modified allogeneic tumor cells in advanced non-small-cell lung carcinoma. Cancer Gene Therapy 10:11, pages 850-858.
Crossref
Crossref
Fraia Melchionda, Terry J. Fry & Crystal L. Mackall. (2003) Harnessing the immune modulatory effects of IL7 for immunotherapy. Clinical and Applied Immunology Reviews 4:2, pages 71-89.
Crossref
Crossref
Denise L. DoolanScott SouthwoodDaniel A. FreilichJohn SidneyNorma L. GraberLori ShatneyLolita BebrisLaurence FlorensCarlota DobanoAdam A. WitneyEttore AppellaStephen L. HoffmanJohn R. YatesIIIIIIDaniel J. CarucciAlessandro Sette. (2003)
Identification of
Plasmodium falciparum
antigens by antigenic analysis of genomic and proteomic data
. Proceedings of the National Academy of Sciences 100:17, pages 9952-9957.
Crossref
Crossref
Jinyan Du, Arlo J. Miller, Hans R. Widlund, Martin A. Horstmann, Sridhar Ramaswamy & David E. Fisher. (2003) MLANA/MART1 and SILV/PMEL17/GP100 Are Transcriptionally Regulated by MITF in Melanocytes and Melanoma. The American Journal of Pathology 163:1, pages 333-343.
Crossref
Crossref
Francesco M Marincola, Ena Wang, Meenhard Herlyn, Barbara Seliger & Soldano Ferrone. (2003) Tumors as elusive targets of T-cell-based active immunotherapy. Trends in Immunology 24:6, pages 334-341.
Crossref
Crossref
Francesco Lozupone, Licia Rivoltini, Francesca Luciani, Massimo Venditti, Luana Lugini, Agata Cova, Paola Squarcina, Giorgio Parmiani, Filippo Belardelli & Stefano Fais. (2003)
Adoptive transfer of an anti‐MART‐1
27–35
‐specific CD8
+
T cell clone leads to immunoselection of human melanoma antigen‐loss variants in SCID mice
. European Journal of Immunology 33:2, pages 556-566.
Crossref
Crossref
Robert J. Arceci & Timothy P. Cripe. (2002) Emerging cancer-targeted therapies. Pediatric Clinics of North America 49:6, pages 1339-1368.
Crossref
Crossref
Helmut W.H.G Kessels, Monika C Wolkers & Ton N.M Schumacher. (2002) Adoptive transfer of T-cell immunity. Trends in Immunology 23:5, pages 264-269.
Crossref
Crossref
T Ramirez-Montagut, D M Andrews, A Ihara, S Pervaiz, F Pandolfi, P J Van Den Elsen, R Waitkus, L A Boyle, M Hishii & J T Kurnick. (2000) Melanoma antigen recognition by tumour-infiltrating T lymphocytes (TIL): effect of differential expression of Melan-A/MART-1. Clinical and Experimental Immunology 119:1, pages 11-18.
Crossref
Crossref
Mark B. FariesIsabelle BedrosianShuwen XuGary KoskiJames G. RorosMirielle A. MoiseHung Q. NguyenFriederike H. C. EngelsPeter A. CohenBrian J. Czerniecki. (2001) Calcium signaling inhibits interleukin-12 production and activates CD83+ dendritic cells that induce Th2 cell development. Blood 98:8, pages 2489-2497.
Crossref
Crossref
Kate M. Lally, Simone Mocellin, Galen A. Ohnmacht, Mai-Britt Nielsen, Maria Bettinotti, Monica C. Panelli, Vladia Monsurro & Francesco M. Marincola. (2001) Unmasking cryptic epitopes after loss of immunodominant tumor antigen expression through epitope spreading. International Journal of Cancer 93:6, pages 841-847.
Crossref
Crossref
H.W.H.G. Kessels, K.E. de Visser, A.M. Kruisbeek & T.N.M. Schumacher. (2001) Circumventing T-cell Tolerance to Tumour Antigens. Biologicals 29:3-4, pages 277-283.
Crossref
Crossref
Galen A. Ohnmacht, Ena Wang, Simone Mocellin, Andrea Abati, Armando Filie, Patricia Fetsch, Adam I. Riker, Udai S. Kammula, Steven A. Rosenberg & Francesco M. Marincola. (2001) Short-Term Kinetics of Tumor Antigen Expression in Response to Vaccination. The Journal of Immunology 167:3, pages 1809-1820.
Crossref
Crossref
James T. Kurnick, Teresa Ramirez-Montagut, Lenora A. Boyle, David M. Andrews, Franco Pandolfi, Paul J. Durda, David Butera, Ian S. Dunn, Elizabeth M. Benson, Sam J. P. Gobin & Peter J. van den Elsen. (2001) A Novel Autocrine Pathway of Tumor Escape from Immune Recognition: Melanoma Cell Lines Produce a Soluble Protein That Diminishes Expression of the Gene Encoding the Melanocyte Lineage Melan-A/MART-1 Antigen Through Down-Modulation of Its Promoter. The Journal of Immunology 167:3, pages 1204-1211.
Crossref
Crossref
G. Walker & N. Hayward. (2001) No evidence of a role for activating CDK2 mutations in melanoma. Melanoma Research 11:4, pages 343-348.
Crossref
Crossref
Robert Weth, Oliver Christ, Stefan Stevanovic & Margot Zöller. (2001) Gene delivery by attenuated Salmonella typhimurium : Comparing the efficacy of helper versus cytotoxic T cell priming in tumor vaccination. Cancer Gene Therapy 8:8, pages 599-611.
Crossref
Crossref
Douglas G. McNeel, Lan D. Nguyen, William J. Ellis, Celestia S. Higano, Paul H. Lange & Mary L. Disis. (2001) Naturally occurring prostate cancer antigen‐specific T cell responses of a Th1 Phenotype can be detected in patients with prostate cancer. The Prostate 47:3, pages 222-229.
Crossref
Crossref
T. R. Petersen, S. Buus, S. Brunak, M. H. Nissen, L. A. Sherman & M. H. Claesson. (2001)
Identification and Design of p53‐Derived HLA‐A2‐Binding Peptides with Increased CTL Immunogenicity
*
. Scandinavian Journal of Immunology 53:4, pages 357-364.
Crossref
Crossref
Rong Wang, Linda J. Dworak & Michael J. Lacy. (2001) A panel immunoblot using co-incubated monoclonal antibodies for identification of melanoma cells. Journal of Immunological Methods 249:1-2, pages 167-183.
Crossref
Crossref
Claes Öhlén, Michael Kalos, Doley J. Hong, Aaron C. Shur & Philip D. Greenberg. (2001) Expression of a Tolerizing Tumor Antigen in Peripheral Tissue Does Not Preclude Recovery of High-Affinity CD8+ T Cells or CTL Immunotherapy of Tumors Expressing the Antigen. The Journal of Immunology 166:4, pages 2863-2870.
Crossref
Crossref
Paul K Wallace, Kwong Y Tsang, Joel Goldstein, Pierpaolo Correale, Todd M Jarry, Jeffrey Schlom, Paul M Guyre, Marc S Ernstoff & Michael W Fanger. (2001) Exogenous antigen targeted to Fc?RI on myeloid cells is presented in association with MHC class I. Journal of Immunological Methods 248:1-2, pages 183-194.
Crossref
Crossref
Roger P. M. Sutmuller, Luc R. H. M. Schurmans, Leonie M. van Duivenvoorde, John A. Tine, Ellen I. H. van der Voort, René E. M. Toes, Cornelis J. M. Melief, Martine J. Jager & Rienk Offringa. (2000) Adoptive T Cell Immunotherapy of Human Uveal Melanoma Targeting gp100. The Journal of Immunology 165:12, pages 7308-7315.
Crossref
Crossref
Hiroshi Nagai, Tatsuya Horikawa, Masahiro Oka, Masamitsu Ichihashi, Isao Hara & Sadao Kamidono. (2000) Elimination of CD4+ T Cells Enhances Anti-Tumor Effect of Locally Secreted Interleukin-12 on B16 Mouse Melanoma and Induces Vitiligo-Like Coat Color Alteration. Journal of Investigative Dermatology 115:6, pages 1059-1064.
Crossref
Crossref
Crystal L. Mackall & Lee J. Helman. (2000) Targeting pediatric malignancies for T cell-mediated immune responses. Current Oncology Reports 2:6, pages 539-546.
Crossref
Crossref
Björn Cochlovius, Marike Stassar, Oliver Christ, Laura Raddrizzani, Jürgen Hammer, Ioannis Mytilineos & Margot Zöller. (2000) In Vitro and In Vivo Induction of a Th Cell Response Toward Peptides of the Melanoma-Associated Glycoprotein 100 Protein Selected by the TEPITOPE Program. The Journal of Immunology 165:8, pages 4731-4741.
Crossref
Crossref
Ian D Davis. (2000) An overview of cancer immunotherapy. Immunology and Cell Biology 78:3, pages 179-195.
Crossref
Crossref
Jean-Baptiste Latouche & Michel Sadelain. (2000) Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells. Nature Biotechnology 18:4, pages 405-409.
Crossref
Crossref
Lynn Lamoreux & Raymond E. Boissy. 2000. Vitiligo. Vitiligo
281
297
.
Yonghong Wan, Peter Emtage, Qing Zhu, Ronan Foley, Andrew Pilon, Bruce Roberts & Jack Gauldie. (1999) Enhanced Immune Response to the Melanoma Antigen gp100 Using Recombinant Adenovirus-Transduced Dendritic Cells. Cellular Immunology 198:2, pages 131-138.
Crossref
Crossref
Bj�rn Cochlovius, Michael Linnebacher, Monika Zewe-Welschof & Margot Z�ller. (1999) Recombinant gp100 protein presented by dendritic cells elicits a T-helper-cell responsein vitro andin vivo. International Journal of Cancer 83:4, pages 547-554.
Crossref
Crossref
Edwin de Zoeten, Victoria Carr-Brendel, Dubravka Markovic, Joyce Taylor-Papadimitriou & Edward P. Cohen. (1999) Treatment of Breast Cancer with Fibroblasts Transfected with DNA from Breast Cancer Cells. The Journal of Immunology 162:11, pages 6934-6941.
Crossref
Crossref
Bj�rn Cochlovius, Astrid Perschl, Gosse J. Adema & Margot Z�ller. (1999) Human melanoma therapy in the SCID mouse:In vivo targeting and reactivation of melanoma-specific cytotoxic T cells by bi-specific antibody fragments. International Journal of Cancer 81:3, pages 486-493.
Crossref
Crossref
Herbert J. ZehIIIIII, Donna Perry-Lalley, Mark E. Dudley, Steven A. Rosenberg & James C. Yang. (1999) High Avidity CTLs for Two Self-Antigens Demonstrate Superior In Vitro and In Vivo Antitumor Efficacy. The Journal of Immunology 162:2, pages 989-994.
Crossref
Crossref
Eva Halapil, Mahmood Jeddi-Tehrani, Anders �sterborg & H�kan Mellstedt. (1999) T cell receptor usage in malignant diseases. Springer Seminars in Immunopathology 21:1, pages 19-35.
Crossref
Crossref
Burkhard Ludewig, Bernhard Odermatt, Salome Landmann, Hans Hengartner & Rolf M. Zinkernagel. (1998) Dendritic Cells Induce Autoimmune Diabetes and Maintain Disease via De Novo Formation of Local Lymphoid Tissue. The Journal of Experimental Medicine 188:8, pages 1493-1501.
Crossref
Crossref
Sharon K.S. Huang, Tetsuro Okamoto, Donald L. Morton & Dave S.B. Hoon. (1998) Antibody Responses to Melanoma/Melanocyte Autoantigens in Melanoma Patients. Journal of Investigative Dermatology 111:4, pages 662-667.
Crossref
Crossref
Jeff Alexander, John Fikes, Stephen Hoffman, Eileen Franke, John Sacci, Ettore Appella, Francis V. Chisari, Luca G. Guidotti, Robert W. Chesnut, Brian Livingston & Alessandro Sette. (1998) The optimization of helper T lymphocyte (HTL) function in vaccine development. Immunologic Research 18:2, pages 79-92.
Crossref
Crossref
Nicholas P. Restifo, Deborah R. Surman, Hongyong Zheng, Peter Palese, Steven A. Rosenberg & Adolfo Garc?a-Sastre. (1998) Transfectant Influenza A Viruses Are Effective Recombinant Immunogens in the Treatment of Experimental Cancer. Virology 249:1, pages 89-97.
Crossref
Crossref
Yutaka Kawakami & Steven A. Rosenberg. (1996) T-cell recognition of self peptides as tumor rejection antigens. Immunologic Research 15:3, pages 179-190.
Crossref
Crossref